Company invites individual and institutional investors as well as advisors to log-on to
VirtualInvestorConferences.com to view presentation
NASHVILLE, Tenn., Nov.7, 2016 /CNW/ -- Cumberland Pharmaceuticals (NASDAQ:CPIX), based in
Nashville, focused on specialty pharmaceuticals, today announced that the November 3 presentation from A.J. Kazimi, Chief Executive Officer of Cumberland
Pharmaceuticals, is now available for on-demand viewing at VirtualInvestorConferences.com.
LINK: http://tinyurl.com/1103postpr
Cumberland Pharmaceuticals' presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder
materials from the "virtual trade booth" for the next three weeks.
Recent Company Highlights
- In May 2016, acquired exclusive US rights to Ethyol®.
- In September 2016, announced a fourth development candidate in pipeline with
Portaban™.
- Total net revenues during the first half of 2016 were $15 million resulting in adjusted
earnings of $2 million or $.13 per share
- Over $90 million in total assets, including over $50 million in
cash and marketable securities.
Learn more about the event at www.VirtualInvestorConferences.com.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription
products designed to improve quality of care and address unmet medical needs.
With a focus on underserved niche markets, including hospital acute care and gastroenterology, we deliver products that serve
patients in the U.S. market. Cumberland also makes its products available to patients
internationally through select strategic partnerships.
While Cumberland's commercial capabilities are focused on the U.S. market, our business
development team is actively pursuing opportunities to make our brands available to patients in markets around the globe.
Our primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. We also
strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients. For more information,
visit our website at http://www.cumberlandpharma.com/
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has
been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet
directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail
investor audience network.
Logo - http://photos.prnewswire.com/prnh/20160129/327291LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-presentation-now-available-for-on-demand-viewing-300358072.html
SOURCE Cumberland Pharmaceuticals
